DALLAS, Dec. 18, 2017 /PRNewswire/ -- RegenLab recently issued a press release announcing its new patent on their PRP kits, and threatened to sue even more Eclipse PRP customers. "Not so fast," says Tom O'Brien, CEO of Eclipse Aesthetics, LLC, "as we will show in court: we have strong defenses against this most recent so-called patent of Regen, not only in the US but worldwide. Eclipse and manufacturer Estar Medical pledge to step-in and defend Eclipse PRP customers sued or threatened to be sued by RegenLab's campaign of harassment."
As the undisputed US sales leader in PRP systems that use a proprietary and patented separation technology, Eclipse continues to be committed to supporting our customers just as we have for the last 25 years. As Eclipse and Estar continue working towards defeating the ill-conceived Regen tactics in the US courts, expect to continue receiving all the customer support with Eclipse PRP and its complete line of products. Eclipse stands by its loyal customers and its "best in class" products. When a manufacturer sues a physician, for whatever reason, it hurts all stakeholders - industry, physicians and patients! Please contact the Eclipse customer care hotline at (800) 759-6876 for any support that is needed!
About Eclipse Aesthetics, LLC
Eclipse Aesthetics®, LLC. manufactures and distributes medical and aesthetic supplies to practices in the United States and internationally. Based out of the United States, Eclipse boasts a large sales force with experienced representatives located in every area of the country to provide hands-on support. We believe in proving products and procedures that are simple to implement, easy to use and are highly effective in providing extraordinary results for both patients and practices. To learn more about the aesthetic sales leader and how to Eclipse the competition, visit www.EclipseMed.com.
CONTACT: Tom O'Brien, [email protected]
SOURCE Eclipse Aesthetics, LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article